Article Details

AstraZeneca buying hypertension-focused CinCor for up to $1.8 billion - Axios

Retrieved on: 2023-01-09 17:27:42

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca buying hypertension-focused CinCor for up to $1.8 billion - Axios. View article details on hiswai:

Excerpt

CinCor went public in early 2022, and major shareholders still include Sofinnova Ventures (13.89%), 5AM Ventures (11.28%), Sofinnova Partners ...

Article found on: www.axios.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up